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To our knowledge, the present report is
the ﬁrst description of an IgE-mediated
anaphylaxis to mint (Mentha piperita)
related to the use of toothpaste.










for suspected nonsteroidal anti-inﬂam-
matory (NSAIDs) hypersensitivity. The
patient had a ﬁrst episode of anaphy-
laxis, characterized by generalized
urticaria and laryngeal oedema, 30 min
after oral intake of metamizol 575 mg
(Nolotil, Boehringer Ingelheim,
Ingelheim, Germany), in June 2008.
She was treated in the emergency room
with i.m. epinephrine and i.v. corticoste-
roid and H1 antihistamine, with
regression of the symptoms, and was
discharge with indication to avoid
metamizol and other NSAIDs. She had
three more anaphylactic episodes, after
12 h, 3 and 5 days, respectively. The
patient reported a relationship between
these episodes and the use of toothpaste
(Colgate, Colgate-Palmolive, New
York, NY, USA, and Sensodyne Pro-
Esmalte, GlaxoSmithKline, London,
UK).
At the Immunoallergy Department, a
challenge test was performed with Senso-
dyne Pro-Esmalte toothpaste use,
being strongly positive and characterized
by immediate (< 5 min) facial urticaria,
abdominal colic and bronchospasm,
requiring immediate treatment with i.m.
epinephrine. The patient performed skin
prick tests (SPT) that were positive to
all tested toothpastes (including
Colgate and Sensodyne Pro-Esmalte).
Consulting the toothpaste’s laboratories
for further information about the tooth-
paste’s ingredients, menthol was found
to be the common ‘ﬂavour’ probably
related to the reactions. The patient
performed SPT with 100% peppermint
oil that was strongly positive (48 mm
mean diameter wheal) and accompanied
by symptoms of rhinitis and conjunctivi-
tis. The same skin test was negative in
10 adult atopic controls. Mint-speciﬁc
IgE measurements by two different
methods (UniCAP, Phadia, Uppsala,
Sweden; and Immulite2000, Siemens
Healthcare Diagnostics, Deerﬁeld, IL,
USA) were negative. SPT and challenge
test with a menthol-free toothpaste
(Elmex menthol-free, GABA Interna-
tional, Therwil, Switzerland) were both
negative. Regardless indication for
avoidance of metamizol, 4 months
after the ﬁrst reaction, the patient had a
new anaphylactic episode, with loss of
consciousness, after administration of
i.v. metamizol prescribed for severe
pain. The patient performed SPT
with metamizol i.v. solution, at a
concentration of 0.4 g/ml, which was
positive (9 mm mean diameter wheal).
CAST, (Bu¨hlmann, Scho¨nenbuch,
Switzerland) to metamizol was negative.
Single-blind placebo-controlled oral
challenges were performed with
etoricoxibe, meloxicam, ibuprofen and
diclofenac, being all negative.
There are few reports of IgE-medi-
ated allergy to toothpaste, being mint
or its cyclic alcohol derivative menthol,
the usual responsible. The ﬁrst imme-
diate reaction was described in 1964 in
a woman with recurrent urticaria after
exposure to different menthol-contain-
ing products that was reproducible in
a challenge with a menthol solution
(1). In 1990, Spurlock et al. (2)
described a patient with asthma
triggered by menthol-containing tooth-
paste. Since then some other cases
were published referring to immediate
hypersensitivity to mint or menthol,
with different clinical presentation
including urticaria, rhinitis and
asthma (3–5). After performing
challenges with menthol-containing
toothpaste, Kawane found a signiﬁcant
decrease in FEV1. The same test was
performed in four patients with asthma
but no menthol induced symptoms and
the result was negative to all. Chal-
lenges were negative with menthol-free
toothpaste (3).
This is a rare case, with an
IgE-mediated anaphylaxis to mint
(Mentha piperita) and also an IgE-
mediated anaphylaxis to metamizol, a
pyrazolone drug, often associated with
IgE-mediated reactions (6), with
tolerance to other NSAIDs. A self-
injectable epinephrine device has been
prescribed, as well as avoidance of
metamizol, daily use of menthol-free
toothpaste and strictly avoidance of
mint and menthol-containing products.
This case emphasizes the importance
of being aware about any possible
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Immunoglobulin E (IgE) mediated food
allergy to members of the Brassicaceae
family is uncommon. The ﬁrst case was
described in 1980 by Panconesi et al. (1)
and was attributed to mustard in a
pizza. Since then, several mustard allergy










allergic reactions to Raphanus have been
reported, one patient with contact der-
matitis (4) and another one with acute
urticaria (5).
Nowadays, adverse events related
with dietary supplements intake are
increasingly reported, but the majority
of the consumers are not aware of the
potential dangers of these natural health
products (6).
The authors report the case of a
56-year-old female patient, with a
history of nonatopic asthma and allergic
rhinitis since childhood. The patient
initiated generalized urticaria, facial
angioedema, and severe bronchospasm
(O2 saturation in room air = 88%),
10 min after the ingestion of a 15 ml
ampoule of Hepatocomplex (Biocol
Laborato´rios, Alcoita˜o, Portugal), a
food supplement used for weight loss.
She was medicated in the emergency
room with i.m. adrenalin, as well as i.v.
corticosteroid and H1 anti-histamine,
with regression of the symptoms. No
other food was ingested in the previous
hours. There was also no strenuous
exercise after the ingestion. The patient
had taken this food supplement previ-
ously with no adverse reaction.
Skin prick test with Hepatocomplex
was performed. Not only was the skin
test positive (5-mm mean diameter
wheal), but it was accompanied by dry
cough that promptly reverted with
inhaled salbutamol. The composition of
this food supplement was analyzed to
ﬁnd the culprit foodstuff. It contained
rosemary (Rosmarinus ofﬁcinalis),
artichoke (Cynara cardunculus), and
black radish (Raphanus niger), as well as
sorbitol, glycerin, lecithin, choline,
arginine, vitamin E, and several oligo-
elements. Prick-prick tests with the ﬁrst
three fresh foodstuffs were performed
and were clearly positive for the black
radish (10.5-mm mean diameter wheal);
the remainders were negative; the
patient also had a positive prick-prick
test (5-mm mean diameter wheal) to
radish (Raphanus sativus). The same
skin tests were negative in 10 adult ato-
pic controls. The patient has no recol-
lection of purposely eating any type of
radish. Ingestion of other members of
the Brassicaceae family did not elicit
symptoms, namely mustard, broccoli,
and cabbages. Avoidance of the Raph-
anus gender has been indicated, as well
as an adrenaline auto-injector was
prescribed for possible hidden allergens,
taking into account the severe nature of
the reaction.
To our knowledge, this report
constitutes the ﬁrst anaphylactic
IgE-mediated reaction to foodstuff of
the Raphanus gender. Our patient
presented a positive skin test with the
raw Raphanus niger, as well as Raph-
anus sativus, a closely related species.
An irritant effect can be ruled out,
because the same skin test was negative
in 10 atopic controls. Although also
suggestive of an IgE-mediated reaction,
in the report of Sayed et al. (5), they
did not perform skin prick or prick-
prick tests and only had a late modera-
tely positive scratch test at 40 min.
Oral provocation test is formally
contra-indicated in our case, given the
clear cut history of severe anaphylaxis
and positive skin test. Allergy to other
constituents of the food supplement
was ruled out. Considering the exten-
sive use of herbal and food supple-
ments, a comprehensive risk-beneﬁt
analysis including a surveillance system
for monitoring the adverse health
effects of these products is essential,
allowing the identiﬁcation of unpredict-
able adverse reactions, namely allergic,
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